Literature DB >> 17440942

Understanding comorbidity: a twin study of reading disability and attention-deficit/hyperactivity disorder.

Erik G Willcutt1, Bruce F Pennington, Richard K Olson, John C DeFries.   

Abstract

A community sample of twins in which at least one member of each pair exhibited significant reading difficulties (99 monozygotic and 80 dizygotic pairs) or symptoms of attention-deficit/hyperactivity disorder (ADHD; 83 monozygotic and 78 dizygotic pairs) was used to test the etiology of comorbidity between reading disability (RD) and ADHD. Univariate analyses revealed moderate to high heritability for all measures of reading difficulty and ADHD. Subsequent bivariate analyses indicated that the relation between reading difficulties and inattention symptoms is primarily attributable to common genetic influences, whereas bivariate heritability estimates were not significant for hyperactivity-impulsivity and any of the reading measures. Reading difficulties and ADHD symptoms were more highly heritable if the proband met criteria for both disorders versus RD or ADHD alone, suggesting that future molecular genetic analyses of comorbid RD + ADHD may facilitate the identification of susceptibility genes for RD, ADHD, and their comorbidity. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17440942     DOI: 10.1002/ajmg.b.30310

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  65 in total

1.  Working memory influences processing speed and reading fluency in ADHD.

Authors:  Lisa A Jacobson; Matthew Ryan; Rebecca B Martin; Joshua Ewen; Stewart H Mostofsky; Martha B Denckla; E Mark Mahone
Journal:  Child Neuropsychol       Date:  2011       Impact factor: 2.500

2.  Gender, attention-deficit/hyperactivity disorder, and reading disability in a population-based birth cohort.

Authors:  Kouichi Yoshimasu; William J Barbaresi; Robert C Colligan; Jill M Killian; Robert G Voigt; Amy L Weaver; Slavica K Katusic
Journal:  Pediatrics       Date:  2010-09-27       Impact factor: 7.124

3.  Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.

Authors:  Linda Wietecha; David Williams; Sally Shaywitz; Bennett Shaywitz; Stephen R Hooper; Sharon B Wigal; David Dunn; Keith McBurnett
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-11-09       Impact factor: 2.576

4.  Are ADHD symptoms associated with delay aversion or choice impulsivity? A general population study.

Authors:  Yannis Paloyelis; Philip Asherson; Jonna Kuntsi
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-08       Impact factor: 8.829

Review 5.  Moving closer to a public health model of language and learning disabilities: the role of genetics and the search for etiologies.

Authors:  Brett Miller; Peggy McCardle
Journal:  Behav Genet       Date:  2011-01-13       Impact factor: 2.805

6.  Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review.

Authors:  Tanya E Froehlich; Jason Fogler; William J Barbaresi; Nada A Elsayed; Steven W Evans; Eugenia Chan
Journal:  Clin Pharmacol Ther       Date:  2018-08-30       Impact factor: 6.875

7.  Association of ADHD and the Protogenin gene in the chromosome 15q21.3 reading disabilities linkage region.

Authors:  K G Wigg; Y Feng; J Crosbie; R Tannock; J L Kennedy; A Ickowicz; M Malone; R Schachar; C L Barr
Journal:  Genes Brain Behav       Date:  2008-11       Impact factor: 3.449

8.  Reaction time variability associated with reading skills in poor readers with ADHD.

Authors:  Leanne Tamm; Jeffery N Epstein; Carolyn A Denton; Aaron J Vaughn; James Peugh; Erik G Willcutt
Journal:  J Int Neuropsychol Soc       Date:  2014-02-17       Impact factor: 2.892

Review 9.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

10.  Atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children with ADHD and dyslexia.

Authors:  Calvin R Sumner; Susan Gathercole; Michael Greenbaum; Richard Rubin; David Williams; Millie Hollandbeck; Linda Wietecha
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-12-15       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.